期刊： BLOOD PURIFICATION, 2022; 51 (10)
The accumulation of protein-bound uremic toxins and medium-large molecule toxins in maintenance hemodialysis (MHD) patients is one of the causes of lo......
期刊： BLOOD PURIFICATION, 2022; 51 (5)
Background: Neointimal hyperplasia (NIH) is believed to be the main reason for arteriovenous fistula (AVF) dysfunction, but other mechanisms are also ......
期刊： BLOOD PURIFICATION, 2022; 51 (3)
Introduction: The impact of early-onset peritonitis (EOP) on patients with diabetes undergoing peritoneal dialysis (PD) has not been adequately addres......
期刊： BLOOD PURIFICATION, 2022; 51 (8)
Background: Anticoagulation-free continuous renal replacement therapy (CRRT) was recommended by the current clinical guideline for patients with incre......
期刊： BLOOD PURIFICATION, 2022; 51 (4)
Background/Aim: This study mainly aimed to explore the therapeutic effects of 3 renal replacement therapy (RRT) modalities on acute kidney injury (AKI......
期刊： BLOOD PURIFICATION, 2022; 51 (9)
Background: Patients with maintenance hemodialysis (MHD) generally have a microinflammatory state. The aim of this study was to investigate the effect......
期刊： BLOOD PURIFICATION, 2022; 51 (2)
Coronavirus disease (COVID-19) is highly contagious and is now a tragic pandemic. Maintenance hemodialysis (MHD) patients are susceptible to COVID-19 ......
期刊： BLOOD PURIFICATION, 2022; 51 (2)
Background: Erythropoiesis-stimulating agents (ESAs) constitute an important treatment option for anemia in hemodialysis (HD) patients. We investigate......
期刊： BLOOD PURIFICATION, 2022; 51 (12)
Introduction: The efficacy of renal-replacement treatment (RRT) remains to be validated in COVID-19. In this retrospective cohort study, we aimed to a......
期刊： BLOOD PURIFICATION, 2022; 51 (4)
Background: Hyponatremia is one of the most common disorders of electrolytes. Some research studies reported that hyponatremia was closely associated ......
期刊： BLOOD PURIFICATION, 2022; 51 (2)
Introduction: Lipid disturbances are common in ESRD patients. In peritoneal dialysis (PD) patients, dyslipidemia is even more common. This study aimed......
期刊： BLOOD PURIFICATION, 2022; 51 (3)
Objective: The objective of this study is to investigate the association between the serum sclerostin, the coronary artery calcification (CAC), and pa......
期刊： BLOOD PURIFICATION, 2022; 51 (5)
Background: The purpose of this study was to observe the impact of an internet-based management system on the incidence of intradialytic hypotension (......
期刊： BLOOD PURIFICATION, 2022; 51 (11)
Background: Radiocephalic arteriovenous fistula (RCAVF) is the best access modality to be considered initially when planning arteriovenous fistula (AV......
期刊： BLOOD PURIFICATION, 2022; 51 (11)
Introduction: When starting continuous renal replacement therapy (CRRT), vasopressor-dependent patients are at risk of hemodynamic instability. Thus f......
